Educational information, not medical advice — ask your doctor or midwife.
Habb-e-Asgand is a time-honoured Unani compound formulation in tablet or pill form, built around Asgand — the Unani name for Ashwagandha (Withania somnifera). Classical Unani texts list it as a Muqawwi-e-Aasab (nerve strengthener) and Muqawwi-e-Bah (reproductive tonic), prescribed for weakness, nervous exhaustion, and declining vitality. Different pharmacopoeial editions specify slightly different companion herbs, but Asgand root is always the lead ingredient and driver of the formula's effects.
Ashwagandha's withanolides and sitoindosides are adaptogenic — they help the body regulate its stress response so that cortisol stays in a healthier range, which in turn supports energy, sleep quality, and mood. The formula also supports testosterone levels in men and helps ease inflammation in joints and muscles. Companion herbs like ginger and long pepper are included in many versions to warm digestion and improve absorption of the active compounds.
The classical form is a small pill or tablet pressed from powdered herbs with a natural binder. Modern licensed Unani manufacturers also produce standardised tablets and capsules that meet pharmacopoeial standards. Quality varies widely across brands — look for products that list Withania somnifera root as the primary ingredient and ideally specify withanolide content.
Asgand has been used in Unani medicine for over a thousand years, referenced in the foundational texts of Ibn Sina (Avicenna) and later codified in South Asian Unani pharmacopoeias. The compound Habb (pill) form was a practical way to deliver multiple supportive herbs together in a precise, portable dose — a tradition that continues in licensed Unani pharmacies across India, Pakistan, and Bangladesh today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.